Status:
RECRUITING
Improving Congenital Heart Disease Care
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Congenital Heart Disease
Behavior, Health
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The theory-informed digital health intervention, called as "Empower My Congenital Health (EmpowerMyCH)" aims to activate and engage ACHD patients in building confidence toward navigating the adult hea...
Detailed Description
The goal of this clinical trial study is to learn whether a digital multi-component intervention would increase the knowledge, self-efficacy, self-advocacy, and patient engagement skills of adults wit...
Eligibility Criteria
Inclusion
- have congenital heart disease
- 18 years or older
- can sign the informed consent
Exclusion
- developmentally delayed
- unable to consent
Key Trial Info
Start Date :
September 5 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06581484
Start Date
September 5 2024
End Date
August 31 2027
Last Update
August 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94117